Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kevin Morgan

Showing results (111-120 of 253) with videos related to

Pageof 26
Sort By:
Neuroimage|October 16, 2002
A functional magnetic resonance imaging study of overt letter verbal fluency using a clustered acquisition sequence: greater anterior cingulate activation with increased task demandCynthia H Y Fu, Kevin Morgan, John Suckling, et al.
International Review of Psychiatry (Abingdon, England)|February 23, 2011
The economic cost of pathways to care in first episode psychosisMargaret Heslin, Paul McCrone, Clare Flach, et al.
Translational Psychiatry|September 4, 2024
Chromosome X-wide association study in case control studies of pathologically confirmed Alzheimer's disease in a European populationEmily Simmonds, Ganna Leonenko, Umran Yaman, et al.
Endocrine-Related Cancer|December 4, 2012
Transcript and protein profiling identifies signaling, growth arrest, apoptosis, and NF-κB survival signatures following GNRH receptor activationColette Meyer, Andrew H Sims, Kevin Morgan, et al.
Pediatric Pulmonology|April 18, 2006
Association of improved pulmonary phenotype in Irish cystic fibrosis patients with a 3' enhancer polymorphism in alpha-1-antitrypsinJulia M Courtney, Barry J Plant, Kevin Morgan, et al.
Human Molecular Genetics|July 7, 2007
Regulatory region single nucleotide polymorphisms of the apolipoprotein E gene and the rate of cognitive decline in Alzheimer's diseaseOlivia Belbin, Janette L Dunn, Yan Ling, et al.
Schizophrenia Bulletin|January 22, 2022
Dynamic and Static Cognitive Deficits in Schizophrenia and Bipolar Disorder After the First EpisodeJolanta Zanelli, Abraham Reichenberg, Sven Sandin, et al.
Cancer Research|August 5, 2008
Gonadotropin-releasing hormone receptor levels and cell context affect tumor cell responses to agonist in vitro and in vivoKevin Morgan, Alan J Stewart, Nicola Miller, et al.
Neuroscience Letters|February 8, 2007
The hydroxy-methyl-glutaryl CoA reductase promoter polymorphism is associated with Alzheimer's risk and cognitive deteriorationElisa Porcellini, Elena Calabrese, Franca Guerini, et al.
Molecular Endocrinology (Baltimore, Md.)|May 10, 2008
Gonadotropin-releasing hormone analog structural determinants of selectivity for inhibition of cell growth: support for the concept of ligand-induced selective signalingRakel López de Maturana, Adam J Pawson, Zhi-Liang Lu, et al.
Pageof 26

Showing results (111-120 of 253) with videos related to

Sort By:
Pageof 26
Neuroimage|October 16, 2002
A functional magnetic resonance imaging study of overt letter verbal fluency using a clustered acquisition sequence: greater anterior cingulate activation with increased task demandCynthia H Y Fu, Kevin Morgan, John Suckling, et al.
International Review of Psychiatry (Abingdon, England)|February 23, 2011
The economic cost of pathways to care in first episode psychosisMargaret Heslin, Paul McCrone, Clare Flach, et al.
Translational Psychiatry|September 4, 2024
Chromosome X-wide association study in case control studies of pathologically confirmed Alzheimer's disease in a European populationEmily Simmonds, Ganna Leonenko, Umran Yaman, et al.
Endocrine-Related Cancer|December 4, 2012
Transcript and protein profiling identifies signaling, growth arrest, apoptosis, and NF-κB survival signatures following GNRH receptor activationColette Meyer, Andrew H Sims, Kevin Morgan, et al.
Pediatric Pulmonology|April 18, 2006
Association of improved pulmonary phenotype in Irish cystic fibrosis patients with a 3' enhancer polymorphism in alpha-1-antitrypsinJulia M Courtney, Barry J Plant, Kevin Morgan, et al.
Human Molecular Genetics|July 7, 2007
Regulatory region single nucleotide polymorphisms of the apolipoprotein E gene and the rate of cognitive decline in Alzheimer's diseaseOlivia Belbin, Janette L Dunn, Yan Ling, et al.
Schizophrenia Bulletin|January 22, 2022
Dynamic and Static Cognitive Deficits in Schizophrenia and Bipolar Disorder After the First EpisodeJolanta Zanelli, Abraham Reichenberg, Sven Sandin, et al.
Cancer Research|August 5, 2008
Gonadotropin-releasing hormone receptor levels and cell context affect tumor cell responses to agonist in vitro and in vivoKevin Morgan, Alan J Stewart, Nicola Miller, et al.
Neuroscience Letters|February 8, 2007
The hydroxy-methyl-glutaryl CoA reductase promoter polymorphism is associated with Alzheimer's risk and cognitive deteriorationElisa Porcellini, Elena Calabrese, Franca Guerini, et al.
Molecular Endocrinology (Baltimore, Md.)|May 10, 2008
Gonadotropin-releasing hormone analog structural determinants of selectivity for inhibition of cell growth: support for the concept of ligand-induced selective signalingRakel López de Maturana, Adam J Pawson, Zhi-Liang Lu, et al.
Pageof 26